Rethinking sterile product development for manufacturing success
Where innovation excels, investment follows. Set against high growth of next-generation modalities, pharmaceutical manufacturing is entering one of its most…
28 Jul 2026
Why the India-UK trade deal now needs a five-gate implementation ledger
Varun Sharma, founder and CEO of NEUVIOR, reflects on the necessitates of the recently forged India-UK pharma trade deal. Varun Sharma, founder and CEO of NEUVIOR The India UK Comprehensive…
02 Jun 2026
Smart pharma is no longer a buzzword: pharma technological breakthroughs at PHARMAP 2026
In recent years, the context surrounding the pharmaceutical industry has been growing towards digitalisation of processes. Manual operations in pharma are disappearing and have now declined to 1% in 2025.…
10 Apr 2026
Advancing single-cell transcriptomics into the mainstream of biomedical research
Kelly Parliament, staff application scientist at Beckman Coulter Life Sciences, discusses how automation is improving the efficiency of single-cell transcriptomic workflows. Kelly Parliament, staff application scientist at Beckman Coulter Life…
11 Mar 2026
Tariffs, uncertainty and disruption: how drug makers and distributors can build operational supply chain resilience
Ryan Rotar, vice president of healthcare market strategy at Tecsys, outlines how supply chain resilience can be maintained in the face of tariffs. Ryan Rotar, vice president of healthcare market…
22 Jan 2026
The new safety mandate driving AI-ready pharmacovigilance
Regulatory expectations in the drug safety industry have evolved faster in the past five years than in the previous two decades combined. The US Food and Drug Administration (FDA), the…
20 Jan 2026
When trillion‑member libraries meet physics: what diversity really means
Dr Karsten Eastman, CEO, Sethera Therapeutics, highlights the challenges around ‘true’ diversification in DNA libraries. In drug discovery, big numbers for screening campaigns are loved. Trillions of molecules! 1020‑member libraries!…